𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Targeting NF-κB Signaling in Multiple Myeloma

✍ Scribed by Bergsagel, P. Leif; Keats, J. Jonathan; Chesi, Marta; Kuehl, W. Michael

Book ID
118629577
Publisher
CIG Media Group, LP.
Year
2009
Tongue
English
Weight
92 KB
Volume
9
Category
Article
ISSN
1557-9190

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NF- B as a Therapeutic Target in Multipl
NF- B as a Therapeutic Target in Multiple Myeloma
✍ Hideshima, T.; Chauhan, D.; Richardson, P.; Mitsiades, C.; Mitsiades, N.; Hayash 📂 Article 📅 2002 🏛 The American Society for Biochemistry and Molecula 🌐 English ⚖ 469 KB
Targeting NF-κB in hematologic malignanc
Targeting NF-κB in hematologic malignancies
✍ Braun, T; Carvalho, G; Fabre, C; Grosjean, J; Fenaux, P; Kroemer, G 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 249 KB
A novel NF-κB inhibitor DHMEQ selectivel
A novel NF-κB inhibitor DHMEQ selectively targets constitutive NF-κB activity and induces apoptosis of multiple myeloma cells in vitro and in vivo
✍ Mariko Watanabe; Md. Zahidunnabi Dewan; Takamitu Okamura; Masataka Sasaki; Kinji 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 453 KB

Multiple myeloma (MM) is a fatal lymphoid malignancy that is incurable with conventional modalities of chemotherapy. Strong and constitutive activation of nuclear factor kappa B (NF-kappaB) is a common characteristic of MM cells. In our study we successfully target NF-kappaB with a novel NF-kappaB i

Alkylating agents induce activation of N
Alkylating agents induce activation of NFκB in multiple myeloma cells
✍ Philipp Baumann; Sonja Mandl-Weber; Fuat Oduncu; Ralf Schmidmaier 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Multiple myeloma is still not curable and drug combination strategies are currently being evaluated in order to achieve high remission rates with tolerable toxicity. Bortezomib has been shown to exert inhibitory effects on NFB activity. NFB in turn is known to be activated by cytokines, growth facto